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To order reprints follow the "Request Permissions" link in the navigation box http://resources.bmj.com/bmj/subscribers INTRODUCTION Angina is the most common initial manifestation of coronary artery disease, with an estimated annual incidence of 2 per 100 population, higher than that for myocardial infarction and other acute coronary syndromes. 1 Prompt assessment, early after presentation, is important to determine the likelihood of coronary artery disease and to identify those patients at risk of adverse cardiac outcomes. 2 3 For these reasons rapid access chest pain clinics were identified as a management standard within the national service framework, with the recommendation that all patients with new onset, stable chest pain should receive specialist assessment within two weeks of referral. 2 Risk seems higher in patients with new onset angina than in those with chronic angina and extends into patients with a diagnosis of non-cardiac chest pain, who accounted for almost one third of cardiac events in a recent study. 4 5 No randomised trials of management strategies in new onset angina have been carried out, however, with most evidence derived from studies in patients with angiographic documentation of coronary artery disease or with previous myocardial infarction. [6] [7] [8] It is generally accepted that the character of the symptoms in patients with suspected angina is central to clinical diagnosis and risk assessment. [9] [10] [11] By convention a resting electrocardiogram (ECG) is recorded and often an exercise ECG, which is a routine investigation in 59% of the chest pain clinics in the United Kingdom 12 and was part of the initial assessment in 76% of patients with angina in the recent Euro heart survey. 13 Whether these investigations contribute incrementally to risk assessment in this group is unknown, as previous studies have focused on cost and feasibility rather than on prognostic value. 14 Other studies of prognostic value have been subject to selection bias through inclusion of patients with previous myocardial infarction or angiographic documentation of coronary disease, [15] [16] [17] [18] [19] [20] and many have restricted analysis to patients without symptoms.
We studied a large cohort of ambulatory patients with recent onset of suspected angina, none of whom had been previously assessed for cardiovascular disease. We identified clinical predictors of coronary events during long term follow-up and determined whether resting ECGs and exercise ECGs provide prognostic value that is incremental to that obtained from the clinical history. , 8176 of 10 634 consecutive patients with new  onset of chest pain referred by their doctor to six chest  pain clinics from 1 January 1996 to 31 December 2002 were included in this study (fig 1) . Fifty one per cent were seen within 72 hours of referral and a further 46% within two weeks. We excluded patients without chest pain, patients with previously diagnosed coronary artery disease (n=858), patients with incomplete data on prespecified covariates (n=685), patients not traced by central registries (n=40), 24 25 and patients whose ethnicity was black or not specified (n=875). From among these 8176 patients (cohort), a total of 4873 (60%) who had an exercise ECG recorded were stratified into two subsets: 4848 patients with a summary test result recorded (positive, negative, equivocal for ischaemia) and 1422 with additional detailed test data recorded. These groups comprised the summary ECG subset and detailed ECG subset for exercise electrocardiography, respectively. The exercise ECG was obtained in all but 7% of patients on the day of the clinic visit.
METHODS
Overall
Data collection
We systematically recorded data in a customised database 26 25 with successful matching in 99.5% of cases. All outcomes were defined by codes according to the World Health Organization international classification of diseases, 10th revision. 27 We used the primary discharge diagnosis to define events among patients undergoing hospital admission during the follow-up period.
The primary end point was a composite of death due to coronary heart disease (code I20-I25) or non-fatal acute coronary syndrome (I20-I23, 124.0, I24.8, I24.9).
27
Statistical analysis
We used Stata version 8.0 for all analyses. We compared the characteristics of the patients in the whole cohort with those in the ECG subsets. Data on patients who underwent coronary artery bypass grafting (code K40-K46) or percutaneous coronary intervention (K49-K50.9) were censored at the time of the revascularisation procedure because of its potential to affect prognosis. Firstly, we carried out multivariable Cox analysis for the primary end point using factors that were statistically significant at the 20% level in univariable analysis for each of three separate models: clinical model (age, sex, typicality of symptoms, heart rate, systolic blood pressure, history of hypertension, diabetes, smoking status), ECG model (QRS axis deviation, pathological Q waves, change in ST segment or T wave, left ventricular hypertrophy, bundle branch block), summary exercise ECG model (positive, negative, or equivocal), and detailed exercise ECG model (exercise time, maximum workload, percentage predicted heart rate, maximum blood pressure, reason for stopping exercise, diagnostic change in ST segment, exertional arrhythmias). We then used the covariates that remained statistically significant at the 5% level in each model to build three incremental models: basic clinical assessment, basic clinical assessment plus resting ECG, and basic clinical assessment plus resting ECG plus either summary exercise ECG or detailed exercise ECG. Then we calculated prognostic indices for each of the incremental models using the regression Mean (SD) age (years) 55 (13) 55 (13) 54 (11) Character of chest pain:
Typical 1939 (24) 1405 (29) 346 (24) Atypical 4785 (59) 3061 (65) 989 (70) Non-specific 1452 (18) 382 (8) 87 (6 Death from coronary heart disease or acute coronary syndrome 576 (7) 351 (7) 110 (8) Death from coronary heart disease 104 (1) 51 (1) 12 (1) Acute coronary syndrome 501 (6) 312 (6) 102 (7) Coronary angiogram 979 (12) 708 (15) 186 (13) PTCA 236 (3) 190 (4) 56 (4) CABG 242 (3) 173 (4) 35 (3) PTCA or CABG 465 (6) 354 (7) 87 (6) PTCA=percutaneous transluminal coronary angioplasty; CABG=coronary artery bypass grafting. *Data were not complete for cohort.
coefficients. To maximise power we developed the basic clinical model and the resting ECG model in the whole cohort and used the summary and detailed ECG subsets to develop the models that include data on the exercise ECG. We forced the variables from the basic clinical model and the resting ECG model into the models with data on the exercise ECGs. We plotted receiver operating characteristics curves and calculated the C statistic with confidence intervals for each prognostic index 28 to examine the incremental prognostic value of the resting ECG and exercise ECG. Curves were plotted for all patients and for patients with intermediate probability of coronary artery disease (20-80%), based on the Diamond and Forrester algorithm, which takes into account age, sex, and typicality of chest pain. 29 Finally, we arbitrarily split the prognostic index into thirds for risk 30 and charted the probabilities of developing an event at one year and six years to illustrate the incremental value of the resting ECG and exercise ECG for each risk category during long term follow-up. (table 1) . Angina was diagnosed in 29% of the cohort, 32% of the summary ECG subset, and 28% of the detailed ECG subset.
RESULTS
Participants in
Covariate screening and prognostic indices Table 2 lists the covariates preselected for multivariate modelling. In the basic clinical assessment model the variables of typical chest pain, age, diabetes, and being male were independently associated with an increased risk of the composite end point of death due to coronary heart disease or non-fatal acute coronary syndrome. In the resting ECG model, variables independently associated with an increased risk of the primary end point were bundle branch block, change in ST segment or T wave, and Q waves. In the summary exercise ECG model the result was associated with the primary end point, and in the detailed exercise ECG model the variables independently associated were exercise time and change in the ST segment on exertion. Table 3 shows the results of the incremental models. In the final iterations (clinical assessment plus resting ECG plus exercise ECG) the major contributors to the risk of the primary end point were typical symptoms and abnormalities on the exercise ECG, with age, sex, and diabetes making variable additional contributions depending on whether the summary ECG subset or detailed ECG subset was analysed.
Receiver operating characteristics curves and C statistic In the cohort, receiver operating characteristics curves for the basic clinical assessment model alone and with iteration for the resting ECG were effectively superimposed with little or no increment in the C statistic (fig 2) . With the iterations for the exercise ECGs the C statistic for the basic clinical assessment model increased in the summary ECG subset from 0.70 (95% confidence interval 0.68 to 0.73) to 0.74 (0.71 to 0.76) and in the detailed ECG subset from 0.74 (0.70 to 0.79) to 0.78 (0.74 to 0.82). When analysis was restricted to patients with an intermediate probability of coronary artery disease (20-80%), the receiver operating characteristics curves for the basic clinical assessment model alone and with iteration for the resting ECG remained effectively superimposed, 
Patient outcomes
Typical chest pain and abnormalities on the resting ECG and exercise ECG were all associated with adverse outcomes (table 4) . Thus point estimates of the probability of the primary end point at three years were 16% for patients with typical chest pain, 15% for patients with an abnormal resting ECG, and 19% for patients with an abnormal exercise ECG, compared with 3%, 5%, and 9% for patients with non-specific chest pain and normal resting and exercise ECGs. However, 47% (n=166) of the events during follow-up occurred in patients with a "normal" exercise ECG, emphasising the limitations of ECGs for risk assessment. Thus in both the summary ECG and the detailed ECG subsets, risk stratified cumulative probabilities of the primary end point at one year and six years for all three prognostic indices (basic clinical assessment, basic clinical assessment plus resting ECG, basic clinical assessment plus resting ECG plus exercise ECG) showed only small differences at all time points and in all thirds of risk (table 5) .
DISCUSSION
In ambulatory patients with suspected angina, the clinical assessment embraces nearly all the prognostic information provided by the resting electrocardiogram (ECG) and exercise ECG. The limited incremental value of these widely applied non-invasive investigations extended across all thirds of risk, emphasising the importance of the clinical assessment and the need for more effective methods of risk stratification in this group of patients. In patients with undifferentiated chest pain there is a gradient of coronary risk, greatest in those with a diagnosis of angina but extending to those with a diagnosis of non-cardiac chest pain. 5 The importance of a careful history is widely acknowledged. Our patients with typical angina, similar to those reported in a previous study, 31 were at higher risk of adverse outcomes than patients with atypical symptoms. Experience of non-invasive testing in patients with undifferentiated chest pain has increased in recent years, but uncertainty about its value for risk assessment remains. 14 We found that a range of abnormalities in both the resting ECG and the exercise ECG were independently predictive of adverse events in ambulatory patients with chest pain of recent onset. It is salutary to note, however, that 47% of all events during follow-up occurred in patients with a negative exercise ECG result, emphasising the limitations of using ECGs for risk assessment, and reminding us that the demonstration of a test's independent prognostic value does not imply clinical utility if it is not incremental to information obtained more simply from the history and examination. In this respect our findings were unequivocal, particularly for the resting ECG, which showed no incremental prognostic value above that of the clinical assessment. For the exercise ECGs, incremental prognostic value seemed somewhat greater as reflected in point estimates for the C statistic, which increased by 5.7% for the exercise ECG subset with summary results and by 5.1% for the exercise ECG subset with more detailed results. Increases were only marginally greater among patients with an intermediate probability of coronary artery disease, the group in which the exercise ECG is most useful for diagnostic purposes. 32 How to interpret such changes in the C statistic has been debated. 33 In clinical terms the incremental prognostic value was trivial (see table 5), with the indices that incorporated data from the exercise ECG proving no more effective than those of the basic clinical assessment in predicting adverse outcomes. Importantly, detailed analysis of variables in the exercise ECG performed little better than the summary assessment that is commonly used in clinical practice.
Previous studies of treadmill testing in chest pain clinic populations have been small and, although confirming feasibility and safety, have not been powered to test prognostic value.
14 Before these studies, a study 15 had developed a prognostic treadmill score in a group of patients referred for cardiac catheterisation, which has since been validated in outpatient populations. 16 Both development and validation groups in these studies contrasted with our patients, however, being predominantly male, often with a history of myocardial infarction and other manifestations of bias from investigations owing to their selection from patients referred for cardiac catheterisation. Application of this score to patients with chest pain of recent onset in chest pain clinics therefore requires caution. Nevertheless, the incremental value of the score for predicting survival at four years in an outpatient population was modest and similar to our exercise ECG model. 16 In another study the increment in the C statistic was similarly modest when the treadmill score was added to the clinical assessment model. 18 More recently, prognostic scores by the ACTION trialists 3 4 and Euro heart investigators 35 have been presented, but these scores utilise data not always available at first presentation and apply to patients with chronic stable angina, many with a history of myocardial infarction and whose risk characteristics are different from the patients with suspected angina in the present study.
The methods in this study are robust and reflect the incremental value of the different statistical models rather than simple comparison of likelihood ratios. We excluded only 7% of patients (n=725) because of missing data or not being traced by central registries. This is unlikely to have affected our conclusions because outcomes in this group were not significantly different from those included in our study. Important limitations were the absence of data on lipid levels and family history, although had these been available they would probably have improved the discriminatory power of the clinical model and would not therefore have affected our conclusions. Similarly, our conclusions would not have been affected by exclusion of the 167 patients (2%) with Q waves, suggesting a history of silent infarction, because this would have further reduced the prognostic value of the resting ECG. An Table 4 | Cumulative probability of composite end point of death from coronary heart disease or non-fatal acute coronary syndrome at one year and six years in patients with suspected angina abnormal exercise ECG result influences decisions on revascularisation, which in turn might influence prognosis. A sensitivity analysis using coronary artery bypass grafting as part of the composite end point did not, however, change the findings. We did not capture the exact magnitude of change in the ST segment during the exercise test, but this is not a serious limitation for prognostic assessment. The presence of such change is indicative of ischaemia but may not correlate with coronary anatomy, 36 37 and agreements on changes in the ST segment can vary between observers. One of the most consistent prognostic markers in exercise testing is maximum exercise capacity, 32 the specific variable (maximum duration of exercise, level of metabolic equivalents achieved, maximum workload, maximum heart rate, double product) used to summarise this being less important. The prognostic importance of age is not undermined by its lack of significance in the final incremental model, which merely indicates that in patients undergoing exercise testing, more prognostic weight is contributed by exercise time, the presence of change in the ST segment, and typical chest pain.
In conclusion, our study emphasises the importance of the clinical assessment for prognosis in patients with suspected angina. The data show that the need to improve risk stratification cannot be met by the resting ECG whereas the incremental value of the exercise ECG is small. Alternative tests are needed but must be developed within cohorts from chest pain clinic because prognostic value depends on the population in which the test is applied. 38 A prerequisite of any new test should be the demonstration of its incremental value over clinical assessment if risk stratification is to be improved and the potential for chest pain clinics to reduce coronary mortality is to be fully realised.
